Bank of New York Mellon’s Catheter Precision VTAK Stock Holding History

Bank of New York Mellon’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$11K	–	4708
2022 Q1	$11K	Hold	3	–	–	﹤0.01%	4638
2021 Q4	$42K	Hold	3	–	–	﹤0.01%	4519
2021 Q3	$84K	Buy	+3	New	+$94.3K	﹤0.01%	4363
2021 Q2	–	Sell	-2	Closed	-$89K	–	4473
2021 Q1	$89K	Buy	+2	New	+$131K	﹤0.01%	4180

Other funds holding VTAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APP

Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BLAM

Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Bank of New York Mellon's VTAK Position: Q2 2022 in Review

Bank of New York Mellon sold out of Catheter Precision (VTAK) in Q2 2022, closing a stake of 3 shares — an estimated $11K sold.

Bank of New York Mellon first reported a position in VTAK in Q1 2021 and held it in 4 quarters. The position peaked at $89K in Q1 2021. 16 funds tracked by Wall St. Rank hold VTAK as of Q2 2022.

Bank of New York Mellon reported no remaining Catheter Precision position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 3 Catheter Precision shares in Q2 2022, an estimated $11K.
Bank of New York Mellon first reported a position in Catheter Precision in Q1 2021 and held it in 4 quarters.
Bank of New York Mellon's Catheter Precision position peaked at $89K in Q1 2021.
16 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.